STELLA CHEMIFA, The Current Fiscal Year Ordinary Profit Revised Upward by 15%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Dec 26, 2024 2:00 pm JST Revision

4109 STELLA CHEMIFA CORPORATION 【J-GAAP】

Guidance Update Report

STELLA CHEMIFA CORPORATION <4109> [TSE Prime] announced a performance revision in the afternoon session on December 26th (14:00). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward 15.5%, from the previous forecast of 3.55 billion yen to 4.1 billion yen (compared to 3.06 billion yen in the previous period), increasing the growth rate from 15.9% to 33.8%.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit is expected to increase 34.7%, from the previous forecast of 1.58 billion yen to 2.13 billion yen (compared to 1.54 billion yen in the same period of the previous year), increasing the growth rate from 2.9% to 38.6%.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	16,340	1,470	1,585	933	77.5	85	Nov 8, 2024	J-GAAP
Oct - Mar, 2024 New	17,340	2,020	2,135	1,333	110.7	85	Dec 26, 2024	J-GAAP
Revision Rate	+6.1%	+37.4%	+34.7%	+42.9%	+42.9%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	34,500	3,650	3,550	2,600	215.9	170	May 10, 2024	J-GAAP
Mar, 2025 New	35,500	4,200	4,100	3,000	249.1	170	Dec 26, 2024	J-GAAP
Revision Rate	+2.9%	+15.1%	+15.5%	+15.4%	+15.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	15,949	1,600	1,540	750	62.4	94	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	17,340	2,020	2,135	1,333	110.7	85	Dec 26, 2024	J-GAAP
YoY	+8.7%	+26.3%	+38.6%	+77.7%	+77.4%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	35,382	3,514	4,347	2,280	186.0	60	May 9, 2023	J-GAAP
Mar, 2024	30,446	2,722	3,064	1,845	153.5	154	May 10, 2024	J-GAAP
Mar, 2025 Guidance	35,500	4,200	4,100	3,000	249.1	170	Dec 26, 2024	J-GAAP
YoY	+16.6%	+54.3%	+33.8%	+62.6%	+62.3%